Correlation Between Swiss Life and Novartis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Swiss Life and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Swiss Life and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Swiss Life Holding and Novartis AG, you can compare the effects of market volatilities on Swiss Life and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Swiss Life with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Swiss Life and Novartis.

Diversification Opportunities for Swiss Life and Novartis

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Swiss and Novartis is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Swiss Life Holding and Novartis AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG and Swiss Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Swiss Life Holding are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG has no effect on the direction of Swiss Life i.e., Swiss Life and Novartis go up and down completely randomly.

Pair Corralation between Swiss Life and Novartis

Assuming the 90 days trading horizon Swiss Life Holding is expected to generate 1.0 times more return on investment than Novartis. However, Swiss Life is 1.0 times more volatile than Novartis AG. It trades about 0.09 of its potential returns per unit of risk. Novartis AG is currently generating about 0.03 per unit of risk. If you would invest  52,090  in Swiss Life Holding on August 27, 2024 and sell it today you would earn a total of  21,270  from holding Swiss Life Holding or generate 40.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Swiss Life Holding  vs.  Novartis AG

 Performance 
       Timeline  
Swiss Life Holding 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Swiss Life Holding are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Swiss Life may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Novartis AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novartis AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Swiss Life and Novartis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Swiss Life and Novartis

The main advantage of trading using opposite Swiss Life and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Swiss Life position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.
The idea behind Swiss Life Holding and Novartis AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio